Co-Authors
This is a "connection" page, showing publications co-authored by Matthew Koshy and Bulent Aydogan.
Connection Strength
1.182
-
Knowledge-based planning for multi-isocenter VMAT total marrow irradiation. Front Oncol. 2022; 12:942685.
Score: 0.225
-
Local Recurrence Following Total Marrow Radiation: Implications for Clinical Target Delineation. Cureus. 2020 Sep 22; 12(9):e10592.
Score: 0.195
-
Frame-based radiosurgery of multiple metastases using single-isocenter volumetric modulated arc therapy technique. J Appl Clin Med Phys. 2019 Aug; 20(8):21-28.
Score: 0.180
-
A preplanning method for stereotactic radiosurgery to improve treatment workflow. J Appl Clin Med Phys. 2016 05 08; 17(3):171-179.
Score: 0.144
-
A preplanning method for stereotactic radiosurgery to improve treatment workflow. J Appl Clin Med Phys. 2016 May; 17(3):171-179.
Score: 0.144
-
The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy. Clin Lung Cancer. 2014 Sep; 15(5):365-71.
Score: 0.126
-
High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT). Eur J Haematol. 2024 Apr 02.
Score: 0.062
-
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018 07; 59(7):1666-1671.
Score: 0.040
-
A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals. Med Phys. 2015 Aug; 42(8):4629-35.
Score: 0.034
-
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014 Dec; 20(12):2034-41.
Score: 0.032